Applications

Comprehensive Cancer Management

Our platform is a powerful tool in the fight against various types of cancer. By accurately profiling Circulating Tumor Cells (CTCs), our technology guides the use of targeted therapies, such as Antibody Drug Conjugates (ADCs), leading to improved patient outcomes and reduced healthcare costs across a broad spectrum of cancers.

Chronic Disease Management

Beyond oncology, Optosense’s technology is highly adaptable for managing chronic diseases. By monitoring circulating cells in the bloodstream, our platform provides vital data that can be used to optimize long-term treatment plans for conditions such as cardiovascular diseases and sepsis

Our technology is being developed to profile biomarkers on Circulating Tumor Cells (CTCs), helping support more informed selection of Antibody Drug Conjugate (ADC) therapies. This approach could enable more personalised treatment decisions based on the characteristics of a patient’s cancer cells.

ADC Treatment Guidance